Literature DB >> 1900396

Depression of ventilation by desflurane in humans.

S H Lockhart1, I J Rampil, N Yasuda, E I Eger, R B Weiskopf.   

Abstract

We studied the ventilatory effects of desflurane (formerly I-653) with and without N2O in healthy male volunteers. After insertion of venous and arterial (radial and pulmonary) catheters, baseline measurements of tidal volume (VT), respiratory rate (RR), ventilatory response to CO2, and arterial and mixed venous blood gases were made. Subjects were randomly assigned to receive either desflurane with O2 (n = 6) or with O2 and 60% N2O (n = 6). Anesthesia was induced by inhalation of desflurane followed by tracheal intubation without muscle relaxants. In each volunteer, at end-tidal concentrations totaling 0.83, 1.24, and 1.66 MAC, we repeated measurements of VT, RR, response to CO2, and arterial and mixed venous blood gases. As depth of anesthesia increased, VT significantly (P less than 0.05) decreased from 363 +/- 22 ml awake to 76 +/- 22 ml at 1.66 MAC without N2O and from 473 +/- 70 ml awake to 128 +/- 6 ml at 1.66 MAC with N2O (mean +/- SE). Similarly, RR increased from 15 +/- 0.5 breaths per min awake to 32 +/- 2 breaths per min at 1.66 MAC without N2O and from 14 +/- 0.5 breaths per min awake to 40 +/- 3 breaths per min at 1.66 MAC with N2O. Desflurane without N2O depressed the ventilatory response to CO2 to 45 +/- 9, 31 +/- 5, and 11 +/- 4% of the awake values at 0.83, 1.24, and 1.66 MAC, respectively. With N2O, values were 52 +/- 14, 23 +/- 5, and 26 +/- 9% of the awake value at 0.83, 1.24, and 1.66 MAC, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900396     DOI: 10.1097/00000542-199103000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Desflurane: the dawn of a new era?

Authors:  J Lerman
Journal:  Can J Anaesth       Date:  1991-11       Impact factor: 5.063

Review 2.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  A clinical assessment of desflurane anaesthesia and comparison with isoflurane.

Authors:  C Lee; W F Kwan; S K Tsai; B J Chen; M Cheng
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

4.  Induction, maintenance and recovery characteristics of desflurane in infants and children.

Authors:  R H Taylor; J Lerman
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

Review 5.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 6.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Desflurane - revisited.

Authors:  Mukul Chandra Kapoor; Mahesh Vakamudi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

Review 8.  The clinical use of desflurane.

Authors:  E I Eger
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.